Anesthesia Pharmacology Flashcards

1
Q

Intravenous Anesthetics

A

The drug will be injected into the arterial (rare) or venous circulation which allows for

  • Rapid distribution to the site of action (usually the brain/CNS)
  • Quick onset of action
  • Titration of “dose to effect”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Disadvantages of Intravenous Anesthetics

A

Possible severe side effects

Anaphylaxis

Phlebitis, thrombophlebitis, PTE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Dose to Effect

A

Intravenous Anesthetics

Dose can be slowly increased until the desired effect is achieved and then will be maintained through a slow continuous infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Tissue Up-Take

A

The rate and amount of the drug absorption is proportional to blood flow and tissue mass

High perfusion or vessel rich organs will receive peak concentrations of a drug within 30 to 60 seconds.

As time passes, the concentration of the drug in the large muscle mass can exceed that of the brain (5 to 10 minutes) therefore continuous infusion is necessary

Lipid soluble agents (Thiopental etc.) will also be taken-up by fat tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Lipid Soluble Agents

A

Ex. Thiopental

Will also be taken-up by fat tissue

The rate may be slow (poorly perfused) but the high mass will cause continued absorption by this tissue, and later, expect slower recovery or more residual effect after administration is discontinued.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Regional Blood Flow

A
  • Vessel Rich Viscera-70%
    • Brain, heart, liver, kidney
  • Muscle-25%
  • Adipose Tissue-4%
  • Vessel Poor Tissue-1%
    • Skin, cartilage, bone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Elimination

A

The removal of intravenous drugs from the body is achieved by

Metabolism: Liver has mixed function oxidase that convert the drug to inactivate variants (Ex. Cytochrome P450)

Excretion: Activated by the normal kidney or through the bile/feces pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Isopropyl Phenols

A

Propofol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Barbiturates

A

Thiopental

Methohexital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Benzodiazepines

A

Midazolam, Diazepam etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Phencyclidines

A

Ketamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Carboxylated Imidazoles

A

Etomidate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Propofol Trade Name

A

Diprivian

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Propofol Dose

A

Loading Dose of 1.5-2.5mg/kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Propofol Use

A

Used in outpatient procedures due to rapid redistribution and elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Propofol Advantages

A

Anti-Emetic

Lack of sumulative effect is helpful for total anesthesia (TIVA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Propofol Side Effects

A

May cause vivid dreams and sexual fantasies during emergence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Propofol Respiratory Effects

A

May cause transient apnea with a reduced response to O2 and CO2

Will not cause bronchospasm

May cause bronchodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Propofol Duration of Action

A

3-8 min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Propofol Elimination Half Life in Hours

A

4-23

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Thiopental Trade Name

A

Sodium Pentothal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Thiopental

A

Slow acting

No analgesic action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Thiopental Dose

A

3-5 mg/kg is used for the initial induction

Slow injection allows for dose to action titration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Thiopental Duration of Action

A

5-10 min redistribution sends more agents to muscle mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Thiopental Half Life
11 hours
26
Thiopental Uses
Induce Unconsiousness
27
Thiopental Side Effets
Decreased cerbral oxygen demand Decreased myocardial function Possible decrease in vascular tone which will lead to hypotension
28
Thiopental Respiratory Effects
Due to it association with an **increased airway reactiveness** this is **not used with asthmatics**
29
Diazepam Trade Name
Valium
30
Diazepam
Widely used tranquilizer Causes pain at peripheral injection site Better to infuse through a central line
31
Diazepam Dose
0.3 to 0.6 mg/kg dose can achieve induction Metabolized by the liver and excreted by the kidney (70%) & bile/feces (30%). Prolonged effect due to first metabolites having nearly as strong an effect as the original drug.
32
Diazepam Duration of Action
15-30
33
Diazepam Elimination Half Life
20-50
34
Diazepam Uses
Pre anesthetic sedation Mild muscle relaxant and anti-convulsant
35
Diazepam Respiratory Effect
Can cause the loss of airway reflexes at high doses and a decrease in tidal volume at lower doses
36
Midazolam Trade Name
Versed
37
Midazolam Dose
0.1 to 0.3 mg/Kg dose. Metabolized by liver---excreted by kidneys Duration of action is 15 minutes---longer than thiopental but less than valium.
38
Midazolam Duration of Action
15-20
39
Midazolam Uses
Cardio-version Intubation Bronchoscopy
40
Midazolam Respiratory Effect
Little effect on RR ## Footnote Can cause the loss of airway reflexes at high doses and a decrease in tidal volume at lower doses
41
Midazolam
A stronger cousin of Diazepam (X2-3) Will have the **same pharmacological action as diazepam,** but also has **anterograde amnesia effects.** The patient will appear awake but will have no memory of the event afterwards Little effect on BP, cerebral blood flow, ICP No pain at injection site
42
Ketamine Trade Name
Katalar
43
Ketamine Dose
Given IV or IM in 1-2 mg/kg dose over 1 minute Duration of action is 5-10 minutes Converted in liver and exreted by kidneys
44
Ketamine Duration of Action
5-10 min
45
Katamine Elimination
2-4 hours
46
Katamine Uses
Will Create a dissociative mental state Used in burns, pediatrics, etc
47
Dissociative Mental State
Catalepsy-Trance like state with muscle rigidity Sedation Amnesia Analgesia
48
Ketamine Side Effects
Increased BP (20-40 mmHg) Increased HR Increased ICP
49
Ketamine Respiratory Effects
Patient can maintain airway
50
Ketamine
Pts need dark, quiet room to recover as can cause hallucinations/bad dreams (emergence delirium)
51
Etomidate Dose
Loading dose: 0.2 to 0.3 mg/kg
52
Etomidate Duration of Action
3-8 min
53
Etomidate Half Life
2.9-5.3 Hour
54
Etiomidate Side Effect
Some adrenal suppression, (which may be advantageous in some pts). Potent cerebral vasoconstrictor.
55
Etiomidate
No Analgesia effects Minimal cardio vascular effects Possible alternative to Propofol or Thiopental
56
Thiamylal
Ultra short acting pentothal Being phased out
57
Methohexital
Cousin of thiopental Faster hepatic extraction therefore less residual drowsiness and less cumulative effect
58
Lorazepam
Cousin of valium Long Duration and Action and Half-Life
59
Inhalation Anesthetics
Major role is the **maintance of anesthesia** after the patient has been induced through another means (ex. IV Thiopental) **Induction can be indicued by these agents** when there is contraindications (ex. small children) These agents are introduced to the body via the respiratory tract and distributed by normal circulation As vapours these agents will behave according to normal gas laws
60
DALTONS’ LAW
Ptotal = P1 + P2 + P3 + P4 etc. ## Footnote The total pressure in a gas mixture is equal to the sum of all the partial pressures. The partial pressure of each gas is proportional to the volumetric percentage of each gas. The partial pressure of each gas is the pressure it would exert if it were alone in the container. Eg. A gas mixture of 10 litres total, containing 100 mL of Halothane vapour is a 1% concentration. (FiHalothane= 0.01) At BTPS, that 1% in a gas would exert a pressure equal to; (760-47) \* 0.01) = 7.13 mmHg.
61
COMPARTMENTS
Compartments can be considered as the different spacesagents need access to, to achieve their desired effect. For inhaled agents the first compartment is the lung. Agents need to traverse the A/C membrane to get to the second compartment --- the blood. The blood--brain barrier needs to allow agents in to get to the usual site of action in the brain (CNS) --- the third compartment. Partial pressure is the primary determinant of diffusion. If pressure equilibrium is achieved, and therefore no pressure gradient exists, movement of agent will stop.
62
Minimum Alveolar Concentartion (MAC)
A measure of a drugs **potency** and is the minimum concentration that is needed in order to prevent the movement of 50% of pt when an incision is made— ## Footnote **The lower the MAC, the more potent the agent.**
63
MAC and Solubility of Sevoflurane
2% in 100% O2 1.1 in 70% N2O B/G Sol CoEf 0.69
64
MAC and Solubility of Enflurane
1. 70% in 100% O2 0. 57% in 70% N2O B/G Sol CoEf 1.9
65
MAC and Solubility of Isoflurane
1. 15% in 100% O2 0. 5% in 70% N2O B/G Sol CoEf 1.4
66
MAC and Solubility of Halothane
0. 77% in 100% O2 0. 29% in 70% N2O B/G Sol CoEf 2.4
67
MAC and Solubility of Methoxyflurane
0. 16% in 100% O2 0. 07% in 70% N2O B/G Sol CoEf 1.9
68
MAC and Solubility Coefficient of Desflurane
6% in 100% O2 3.50% in 70% N2O B/G Sol CoEf 0.6
69
MAC and Solubility Coefficient of Nirtous Oxide
104% Sol CoEf 0.47
70
Stacking MACs
The different MACs of agents can be combined for greater effects, but combing them is not precise and there can be a range of reactions
71
What Are Factors That Will Increase MAC
—Hyperthermia —Drug use —Chronic alcohol abuse —Amphetamines —CNS stimulants
72
What Are Factors That Will Decrease MAC
—Advanced age —Hypothermia —Severe hypotension —Other agents; opiates,valium —Acute drug or ETOH intox. —Pregnancy —High PCO2, Low PO2
73
What Factors Will Not Influence MAC
Gender Duration of anesthesia Mild hypercapnia Hypocapnia Mild anemia Mild acid-base imbalance Hypertension.
74
Cumulative Effect
—Patient may well have been given: * Pre-operative sedation. * Induction agent---Propofoletc. * Intra operative opioids. * Muscle relaxants. * Halogenated hydrocarbons. —All agents can contribute to the depth of anesthesia. Repeated assessment of the depth of anesthesia is mandatory. Vital signs, tearing, obvious movement, etc.
75
Alveolar Uptake is Determined By
* —Inspired concentration ( [] effect) * —Washout of alveolar gas * –Alveolar ventilation * –Functional residual capacity * —Uptake by pulmonary blood flow * –Solubility of agent in blood * –Cardiac output * –Alveolar-mixed venous tension gradient
76
Oil to Gas Solubility
The more soluble the gas the more potent it is
77
Second Gas Effect
Because nitrous oxide has a low blood solubility it will equlilbrate very fast, it also has a large MAC meaning you can use a lot of it before you will ever see the affects. Due to this we can combine nitrous oxide with other inhaled drugs to help them equalibrate faster — Solubility is related to the speed at which a drug will enter the blood/brain Potency is how much you need of a drug to see effect So second gas effect is combining drugs with low solubility (nitrous oxide) with drugs with high potency allowing for quicker induction and less quantity of any particular component.
78
Drug / receptor affinities.
Different drugs will have different affinities for one type of receptor OR the same drug may have different affinities for similar but different receptors. ## Footnote —Drugs can be active on enzyme function and not receptors. General anesthetic inhaled agents seem to have no specific receptor site but are highly lipid soluble and cause some CNS cell membrane changes. —Generally speaking, drugs that excite the CNS (amphetamines), will increase the MAC; drugs that depress the CNS (sedatives/hypnotics, tranquilizers, narcotics) will decrease the MAC. —If a drug like valium was to decrease the MAC by 20% it could be said to contribute a MAC fractionof 20%.
79
General Anesthesia Therories Meyer Overton
—Critical volume hypothesis, cell membrane volume swelling or expansion may obstruct ion channels and therefore electrical activity.
80
General Anesthesia Therories Membrane Fluidization
—Lipids surrounding an ion channel that are normally a semi-rigid gel, may liquefy and block the channel.
81
General Anesthesia Therories GABA
—GABA = gamma-aminobutyric acid A neurotransmitter that binds to receptors on CNS neurons, to inhibit their action may be potentiated by anesthetic agents. The GABA binding/blocking is strengthened.
82
Nitrous Oxide
Blue Tank Shoulder ## Footnote —Mac of 104%. Very lowsol CoEf. —Often used as a 70% strength with balance O2. **—Weak anesthetic, good analgesic.** ‘Entonox’ 50/50. —Used in combination with a narcotic analgesic and muscle relaxant, and a stronger anesthetic. Some respiratory and myocardial depression
83
Enflurane
Orange Tank Color ## Footnote Pleasant odor Good muscle relaxant Muscle relaxant properties similar to IsoF.
84
Isoflurane
Purple Tank Color ## Footnote —Dose related decrease CNS, slight increase ICP (Tx w/hypervent) Potentiates non-depolmuscle relaxants ( decreased by 1/3).
85
Desflurane
Blue Tank Shoulder ## Footnote **Least potent (MAC 6%)** **Least soluble (rapid induction and recovery)** **—Sympathomimetic Properties:** Dose related tachycardia / hypertension, very resistant to biodegradation therefore little chance of systemic toxicity.
86
Sevoflurane
Yellow Tank Color ## Footnote Non pungent odor, (is used for induction)
87
Des Cardiovascular Effects
**BP:** Increase **CO:** No Change **SVR:** Increase **HR:** Increase
88
Sevo Cardiovascular Effects
**BP:** Decrease **CO:** No change **SVR:** Decrease **HR:** Increase No PVC’s.
89
IsoFl Cardiovascular Effects
Mild Cardiac Depressant Few PVR, will not cause MI but may contribute to "coronary steal"
90
EnFl Cardiovascular Effects
Although PVCs are less common, circulatory depression is greater than others.
91
Des Respiratory Effects
Decrease Vt Increase RR Bronchodilation Coughing and breath hold if given quickly
92
Sevo Respiratory Effects
Decrease Vt Increase RR Bronchodilation Dose related resp depression of both central and peripheral chemoreceptors.
93
IsoFl Respiratory Effects
Decrease Vt Small Increase RR Decrease MV Good Bronchodilation
94
EnFl Respiratory Effects
Decrease Vt Increase RR Increase Upper Airway Irritability Potent respiratory depressant
95
EnFl Cautions
CO Decrease Abnormal EEG and may cause seizures during hypocapnia Potential nephro-toxic to pts with kidney disease.
96
IsoFl Cautions
Uterine relaxant, may incidence of and severity of post-partum hemorrhage.
97
Des Cautions
MAC of 6%
98
Sevo Cautions
MAC of 2%
99
Servo Drug Interactions
Decrease dose of muscle relaxant needed
100
IsoFl Drug Interactions
Decrease dose of muscle relaxant needed
101
Des Drug Interactions
Decrease dose of muscle relaxant needed
102
EnFl Drug Interactions
Decrease dose of muscle relaxant needed
103
Enfl Comments
Potential nephron toxic to kidney patients
104
IsoFl Comments
Good for neuro-surgery, stable ICP, low Sol CoEf
105
Servo Comments
Plesant smell Low Sol-Coef
106
Des Comments
Irritating smell Low sol-coef, boils at 23.5oC Dispensed as a gas from a heated vaporizer.
107
Inhaled Gases Solubility
HE IS Dumb N2O Halothane Enflurane Isoflurane Sevoflurane Desflurane Nitrous Oxide
108
Halogenated Hydrocarbons and Respiratory Effects
Both hypercapnic and hypoxic systems are depressed (EnFl is worst) —Bronchodilationis caused by all, best with Halo. —Hypoxic vasoconstriction is depressed by IsoFl. —Halo and EnFlcan cause decreased cilliary function.
109
Halogenated Hydrocarbons and Hepatic and Renal Effects
—All will reduce liver perfusion, Halo the most. —Renal blood flow is decreased by all —High concentrations of EnFl has caused nephro-toxicity.
110
Halogenated Hydrocarbon and Metaboism, Toxicity, and Carcinogenicity
—Halothane undergoes the most extensive reductive metabolization (up to 40%) ---- Isoflurane+ Des the least. TOXIC in high doses: Halo---hepato, EnFl---nephro​ —Avoid all inhaled agents where the pt may be in the first trimester of pregnancy. (TIVA)
111
Muscle Relaxants
Paralyzers Muscle relaxants must NEVER, EVER, be given without sedation.
112
Muscle Relaxant Caution
—Profound muscle relaxation is necessary during intubation and many operative procedures. —Neuromuscular blocking agents have occasionally been used as a substitute for adequate anesthesia or for pharmacological restraints for combative patients. —It should be remembered that these drugs can cause total muscle paralysis and therefore the ability to intubate and ventilate the patient must be available before indiscriminant use is contemplated.
113
Parasympathetic Autonomic Pathway
**Natural Agonists:** Noreepinephrine (no effect), Epinephrine (no effect), and Acetylcholine (strong effect) **Artifical Agonists:** Muscarine Pilocarpine **Heart and Blood Vessel Effect:** Decrease HR and Force vasodilation **Antagonists:** Atropine and Scopolamine **Degradation Blockers:** Anti-cholineresterase
114
Beta Adrenal Autonomic Pathway
**Natural Agonists:** Noreepinephrine (weak effect), Epinephrine (strong effect), and Acetylcholine (no effect) **Artifical Agonists:** Isoproterenol (B1 and B2) **Heart and Blood Vessel Effect:** Increased HR and Force vasodilation **Antagonists:** Propranolol **Degradation Blockers:** Monoamiine Oxidase Inhibitros and CCMT Inhibitors
115
Alpha Adrenal Autonomic Pathway
**Natural Agonists:** Noreepinephrine (strong effect), Epinephrine (Weak effect), and Acetylcholine (no effect) **Artifical Agonists:** Phenylephrine **Heart and Blood Vessel Effect:** Constriction **Antagonists:** Phentolamine **Degradation Blockers:** Monoamiine Oxidase Inhibitros
116
Synaptic Architecture
—-\>Action potential travels to synaptic end bulb ►ACh(or other) neurotransmitter spills out ► Post synaptic receptor takes up ACh, yields an action potential which
117
Types of Muscle Relaxants
—Non-depolarizing:Blocks action potential without depolarizing post-synaptic neuron. —Depolarizing:Blocks action potential by depolarizing post-synaptic neuron and preventing effective re-polarization.
118
Long Acting Non-Depolarizing Agents
d-Tubocurarine Pancuronium
119
d-Tubocurarine
Original Gold Standard Quick onset Last 30-45 min –Loading dose 0.4 mg/Kg, depolarizing and anesthetic agents will potentiate effect. –Histamine release and sympathetic block result in hypotension Caution with asthma
120
Pancuronium
**Trade Name:** –Pavulon® **Duration of Affect:** Quick acting, lasting 45-60 minutes **Loading Dose:** 0.08 mg/kg Depolarizing and anesthetic agents will potentiate effect. Small histamine release Action on vagus nerve (**parasympatholytic**) and catecholamine reuptake depression causes tachycardia and perhaps BP.
121
Long Acting Non-Depolarizing Agent
Metocurine Pipecuronium Doxacurium Alcurnium
122
Metocurine
Similar to d-tubo 0.2 mg/kg no histamine release Can cause hypotension Avoid renal failure
123
Pipecuronium
Derivative of pabcuronium 0.05 mg/kg Minimum cardiac effect
124
Imtermediate Acting Non-Depolarizing Agents
Gallamine Atracurium Vecuronium Cisatracuriumaka NimBex
125
Gallamine
Strength = d-Tubox 0.2, 2.0 mg/Kg –Quick acting, lasts 20+ minutes, little or no histamine release, cardiac vagal blockade causes sinus tachycardia. Contraindicated in renal failure.
126
Atracurium
0.4 mg/Kg –Quick acting Lasts 20+ minutes Relative cardiac stability
127
Vecuronium
0.08 mg/Kg –Quick acting Last 25+ minutes
128
Cisatracuriumaka NimBex
4-5 times more potent than Rocuronium –Rocuronium has a faster onset, shorter duration, and faster recovery when compared to cisatracurium.
129
Rocuronium
**Trade Name:** Zemuron **Loading Dose:** 0.3-0.5 mg/min **Onset Time:** 60-90 seconds (ideal for RSI) **Intermediate Duration of Action:** 35-45 min **Continuous Infusion** (seldom done): 4-16 mcg/kg/min
130
Neostigmine
Used with atropine to end the effects of non-depolarizing neuromuscular blocking medications
131
Pyridostigmine
10 – 20 mg given with a half dose of Atropine Slower onset but longer duration
132
Short Acting Non-Depolarizing Agents
Mivaurium
133
Mivacurium
Dose 0.15 mg/kg Very short acting (15 min) May cause hypotension due to histamine release
134
Reversal Mechanisms & Drugs
* How long a drug works for will depend upon amount used, distribution throughout the body, and metabolic and excretion pathways
135
Anticholinesterase Drugs
Neostigmine Pyridostigmine Edrophonium
136
Anticholinesterase
Using anticholinesterase allow concentration of ACh to build up which will complete with the drug at the neuromuscular junction ​ If the block is severe, the clinician will wait until some degree of muscle function has returned.
137
Edrophonium
Tensilon® 1 mg / Kg (Small doses are ineffective in that they may allow relaxation to return) Quicker onset and less muscarinic side effects. (like bradycardia, salivation etc
138
Sugammadex
**Reversal of neuro bloackade without inhibition of acetycholinesterase** meaning it will **not cause autonomic instability** **Atropine do not need to be co-administered** **Greater cardiovascular and autonomic stability than the traditional reversal agents**
139
Factors Effecting Action of Non-depol MR
—Priming —Age —Hypothermia —Acid-Base Status —Electrolyte Imbalance —Renal Failure —Myasthenia Gravis —Eaton-Lambert (myasthenic-Oat Cell CA) —Other Drug Interactions
140
Priming
—A 10% dose of MR given prior to the actual need for anesthesia allows a much smaller dose to be given later. —This will cause some paralysis in a small number of patients but allow easier reversal in the majority.
141
Age and Non-Depolarizing Muscle Relaxants
—The very young (neonates and premies) have underdeveloped synaptic architecture. —The very old may have decreased muscle mass and slower renal function. —These conditions may dictate less MR needed to gain desired effect therefore less reversal agent.
142
Hypothermia and Non-Depolarizing Muscle Relaxants
—Although cooler tissue is somewhat resistant to MR (more needed), the renal function is also slowed (more retained). —Net result is a prolonged duration of action. — —
143
Electroylte Imbalance and Non-Depolarizing MR
—Acute onset hypokalemia, potentiates MR action and depresses Neostigmines’ ability to reverse.
144
Acid-Base Imbalance and Non-Depolarizing MR
—Respiratory acidosis, metabolic alkalosis potentiate the MR, but metabolic acidosis seems to decrease the action of MR.
145
Renal Failure and Non-Depolarizing MR
—Drugs whose primary detoxification pathway is renal, will obviously stay in relatively high concentration in the patient with renal failure. —The counterbalance is that the reversal drugs like neostigmine will also have a prolonged effect. —Drugs with a high hepatoclearance pathway will not be as effected and the clinician may need less reversal agent if its’ main clearance route is nephro.
146
Myasthenia Gravis and Non-Depolarizing MR
There will be antibodies that compete with ACH and will block or depress the action of ACH —
147
Eaton-Lambert Syndrome and Non-Depolarizing MR
Impaired Ach release mechanisms. More susceptible to both depolarizing and non-depolarizing agents.
148
Inhaled Agents Drug Interactions
All inhaled agents will potential non depl MR— —
149
Succinylcholine Drug Interactions
—Succinylcholine can before intubation to potentiate MRs by up to 20%. Therefore pts hould be showing signs of recovery from ‘Succs’ before more MRs are given. —
150
—Magnesium Sulfate Drug Interactions
—Magnesium Sulfate (for seizures) antagonizes the action of calcium at the motor end plate therefore enhancing the blockade. —
151
—Calcium channel blockers Drug Interactions
—Calcium channel blockers like verapamil will enhance the neuromuscular block. —
152
—Aminoglycosides Drug Interactions
—Aminoglycosides (streptomycin and others) potentiate non-depolMRs.
153
——Anti-convulsants Drug Interactions
—Anti-convulsants like phenytoin and carbamazepine will actually depress the action of non-depol MRs.
154
Depolarizing Muscle Relaxants
—Normally all muscles have some tension. —They will increase tension if stretched. —Peripheral surgery may require little relaxation. —Deeper procedures need complete muscle flaccidness.
155
Succinylcholine (Anectine)
**Dose:** 1-2 mg/kg **Duration of Action:** 3-5 min Produces a constant depolarization resulting in isotonic contractions and fasciculations Rapid paralysis and vagal stimulation may lead to cardiac arrhythmias —Broken down by plasma (or pseudo)-cholinesterase.
156
Succinylcholine Side Effects
Arrhythmia Salivation Muscle pain and spasm— Increased pressures (ex. gastric, ICP, ocular) Increased potassium which is why it is not used with burns
157
Succinylcholine Factors Effecting Action
◦Pre-curarization, small pre-dose of NonDepol ◦Self-taming,small pre-dose of Succs ◦Myotonia, succsmay aggravate, see next slide ◦Myasthenia Gravis, IgG antibodies block site ◦Atypical Plasma Cholinesterase, ↓breakdown ◦Others
158
Myotonia
—Fainting Goats —The inability to relax a muscle group, common to MD pts.
159
Narcotic Analgesics
Morphine and derivatives allow good hemodynamic stability (but reduced ventilatory drive) and have been used as sole agents in anesthesia. Analgesics are generally used to relieve pain with no loss of consciousness. (normal dosages)
160
Mechanism of Action: Multiple Sites
Triggers a recpetor on a CNS neuron which will activate a G protein and become an inhibitory force The action of Ca ion channels will become depressed Substance “P” from sensory neurons in the spinal cord is involved in sending painful sensations to the brain. Opioids inhibit this transfer. There are changes in nociception in the forebrain as well.
161
Opioid Receptors Delta
**Effects:** Analgesic effects in CNS & spinal cord, changes in affective behavior, no sedation, some ventilatorydepression **Agonists:** Enkephalins
162
Opioid Receptors Kappa
**Effects:** Analgesic effects in CNS & spinal cord, miosis(small & possibly unequal pupil size), sedation, littleventilatorydepression **Agonists:** Dynorphins
163
Opioid Receptors Mu
**Effects:** Analgesic effects in CNS & spinal cord, respdepression, constipation, N&V, euphoria, physical dependence, bradycardia **Agonists:** Endorphins, Morphine, Synthetic Opioids
164
Opioid Receptors Antagonists for All
Naloxone (Narcan) Naltrexone (Revia; used in morphine and alcohol dependence therapies.)
165
Opiods Absorption
•Morphine and other opiates are very well absorbed by the lungs, mucosa, subQ tissue or muscular injection and less well through the GI tract.
166
Opiods Distribution
Morphine’s main action is in the CNS, but transport across the blood brain barrier is relatively slower than other lipid soluble narcotics. Dependent on the site of injection.
167
Opoids Uses
* For relief of pain during and after surgery. * Subcutaneous injection; 10–15 mg. * IV 1 –2 mg (­dose, titration against analgesia). * Can be used to induce anesthesia in larger doses. * As a premedication with atropine (vagolytic).
168
Systemic Effects of Opioids CNS
* Both a stimulant and a depressant. * Stimulation—pupils constrict, N & V, spinal reflexes (muscle rigidity), convulsions. * Depression---analgesia, sedation, mood changes (tranquil, drowsy), hypoventilation. * Possible miosisin high doses. * Other Effects: No direct action on cerebral circulation if PCO2is controlled. Depressedneuro-function and pupillary constriction hampers neuro-assessment.
169
Systemic Effects of Opioids Respiratory
* The Mu effect will depress the respcenters in the brain stem. * Vtseems preserved but RR decreases. Overdose causes death by hypoventilation. * Use with great caution in asthmatic or COPD pts.
170
Systemic Effects of Opioids Cardiovascular
•Dose dependent bradycardia, contractility preserved. Decreased SVR due to peripheral vasodilation (resistance and capacitance vessels) and peripheral histamine release. Little worry with healthy, supine pt. in usual dosages
171
Systemic Effects of Opioids
* Stimulates the smooth muscle of the GI tract leading to ineffective peristalsis, increased transit time and constipation. * Spasm of Oddi’ssphincter (liver) and biliary backup can cause acute angina like pain. * Relieved by nitro-glycerin (relieves both biliary pain and angina) or naloxone (Narcanâ) •
172
Tolerance and Addiction
* After repeated use, toleranceto these drugs requires increasing dose for the desired effect. * Usually reversible with 2-3 week abstinence. * Addictionis psychological and physical ---- after 8 or more hours of abstinence, dependence presents as; Restlessness, anxiety, tearing, rhinorrhea, N&V, diarrhea, hypertension, tachycardia, cramps and muscle ache.
173
Potency
•Potency refers to the amount of drug (usually expressed in milligrams) needed to produce an effect, such as relief of pain or reduction of blood pressure. For instance, if 5 milligrams of drug A relieves pain as effectively as 10 milligrams of drug B, drug A is twice as potentas drug B.
174
Efficiacy
* refers to the potential maximum therapeutic response that a drug can produce. * For example, the diuretic LASIX eliminates much more salt and water through urine than does the diuretic DIURIL. Thus, LASIX has greater efficacythan DIURIL.
175
Potency and Efficicay
* , greater potency or efficacy does not necessarily mean that one drug is preferable to another. * When judging the relative merits of drugs for a patient, clinicians consider many factors, such as side effects, potential toxicity, duration of effect (which determines the number of doses needed each day), and even cost.
176
Responsiveness
* "Responsiveness"of a particular patient to therapy with opioids would then refer to the success of therapy (regardless of dose) in terms of reducing pain to an acceptable level with acceptable side effects. * Therefore the differences in potencies between different opioids becomes much less important than which drug produces the right balance between analgesia and side effects. * The relative potencies of various opioids becomes important only when trying to switch opioids while maintaining equipotent analgesic effects.
177
IM vs PO
* The standard accepted ratio of the relative potency of IM to PO Morphine is 1:6. * Interestingly, this ratio seems to change with chronic dosing such that the ratio of IM to PO becomes 1:2-3. * The ratio of potency of immediate release morphine to sustained or controlled-release of morphine remains 1:1.
178
Other Opioid Like Drugs
Meperidine (Dermerol) Fentanyl Papaveretum Alfentanil **Remifentanil** **Carfentanil**
179
Meperidine
•Demerol 10-15mg IV, 75-125 mg IM * Synthetic morphine, dry mouth and blurred vision. * Less constipation, less pupillary constriction. * May¯myocardial function in high dose. * Shorter period of action than morphine.
180
Fentanyl
•Fentanyl 100 times stronger than morphine (or Sufentanil which is 5x-10 stronger than fentanyl). Short duration of effect, severe respdepression.
181
Papaveretum
50% Morphine
182
Alfentanil and Remifentanil
reduced potency---rapid elimination ---- quicker recovery
183
Carfentanil
= Fentanyl x 100 200 ug is fatal.
184
Opioid Reversal
Naloxone (Narcan) * Respiratory depression to the point of apnea is a hallmark of morphine overdose. * This opioid antagonist causes RR to increase, pupils to dilate, blood pressure to normalize and the patient to awake. * The adult dose of 100 mg IV, starts immediately and effects can be seen in 1 to 2 minutes. Short acting, repeat dose until desired effect is obtained, (ptcan return to lalaland). * Overdose of Narcanmay cause hypertension and agitation. Naltrexone is an oral version given to addicts to blunt morphine euphoria and therefore desire.
185
Codeine
* natural opium alkaloid. * 10 to 15% the strength of morphine parenterally. * Low first pass hepatic clearance allows for oral delivery, liver converts some to morphine. * Eventual conjugation in liver and excretion by kidneys. * Usually used topically, IM or subQ. Has been used IV, in neurocases and ambulatory patients but is seldom used parenterally. Semi synthetic derivatives: Oxycodone with ASA or acetaminophen----orally; hydrocodone is also used with antitussive medications
186
Analgesic Ladder
—When using the pharmacological approach please keep in mind the following recommendations: —Use the simplest dosage schedules and least invasive pain management modalities first. —For mild to moderate pain, use (unless contraindicated) aspirin, acetaminophen, or non-steroidal anti-inflammatory drug (NSAID; WHO ladder, Step 1). —When pain persists or increases, add an opioid (WHO ladder, Step 2). —If pain increases, increase the opioid potency or dose (WHO ladder, Step 3). —Schedule doses regularly (i.e., "by the clock") to maintain the level of drug that will help prevent recurrence of pain. Ask for patient and family cooperation in establishing the effective level. —Administer additional doses "as needed" for breakthrough pain NSAIDs reduce the production of prostaglandin E2 (PGE2) and prostacyclin (PGI2), which mediate pain and inflammation.
187
Adjuvant Drugs
—Used off label in conjunction with opioids ◦Anti-depressants ◦Anti-seizure meds ◦Muscle relaxants ◦Sedatives ◦Anxiolytics ◦Marijuana (what label?) ◦Botulinum Toxins
188
Botulinum Toxins
When **injected in small amounts**, it can effectively **weaken a muscle for a period of three to four months**. It is used in the **treatment of spasms and dystonias**. Botulinum is the most acutely lethal toxin known. LD50 = 1-2 ng/kg IV-IM
189
Distribution and Re-Distribution
First plasma will have the highest concentration Next the viscera will reach peak concentration and the plasma concentration rapidly drops Muscle mass takes longer to reach peak concentration and when it does the concentration in both the plasma and viscera will have dropped As the muscle concentration begins to decrease adipose tissue will begin to gain concentration
190
What drug is used as last attempt treatment for refractory status asthmaticus
Ketamine
191
MAC From Lowest to Highest
Megan Has Isolated Evil Serious Dream Nightly Methexyfluane (0.0016) Halothank (0.0077 Isoflurane (0.115) Enfluurance (0.0170) Servo (0.02) Des (0.06) Nirtrous Oxide (1.04)
192
Sevo CNS Effects
Dose related depression Increased ICP which is the brains’ response to high PaCO2 (­increased RR decreased Vt) is preserved.
193
Nociception
Ability to feel pain, caused by stimulation of a nociceptor. Composed of four processes: transduction, transmission, modulation, andperception.
194
—Halo Hepatitis
Post operative fever, eosinophilia and liver dysfunction (elevated enzymes) is very rare. Pts with four of: age, femaleness, sepsis, obesity, biliary surgery, drug dependency, long procedures, multiple procedures, multiple allergies----should be given another agent.